Lincomycin Hydrochloride Injection shortage
Lincomycin Hydrochloride Injection is currently listed in shortage by the FDA. The FDA lists 3 affected products. This page was last refreshed from FDA data on Oct 2, 2026.
Both Pfizer and XGen Pharmaceuticals have decided to permanently stop making Lincomycin Hydrochloride Injection. Other makers — Pharmacia & Upjohn and Sagent Pharmaceuticals — have not reported a shortage and still list Lincocin (lincomycin hydrochloride) 300 mg/mL injection as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Lincomycin Hydrochloride Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Mar 26, 2026Currently in shortage3 of 3 products affected.
-
Mar 26, 2026More presentations reported2 more products added to the shortage.
-
Feb 25, 2026First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Pfizer Inc. 📞 844-646-4398 1 NDC click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04) | — | — | Discontinuation of the manufacture of the drug | — |
Manufacturer: XGen Pharmaceuticals DJB, Inc. 📞 866-390-4411 2 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Lincomycin Hydrochloride Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Lincomycin Hydrochloride Injection? options further down this page.
Why is Lincomycin Hydrochloride Injection in shortage?
This shortage is happening because the manufacturers who reported it to the FDA have decided to permanently stop making their versions of lincomycin hydrochloride injection. XGen Pharmaceuticals made the decision to discontinue both their 3 grams/10 mL vials (sold in packs of 10) and their 600 mg/2 mL vials (also in packs of 10). Pfizer has also chosen to stop making their brand-name version, Lincocin, in the 2 mL multiple-dose vial. All three of these specific products are being permanently discontinued.
It's worth knowing that this report reflects only what these two companies shared with the FDA — it covers their specific products and package sizes. No information was given about any remaining supply timelines or about any strengths or sizes that will continue to be made by these manufacturers.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Lincomycin Hydrochloride Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Lincomycin Hydrochloride Injection?
Lincomycin Hydrochloride Injection is currently on the FDA drug-shortage list. I want to walk you through what this means so you know your next step.
At this time, none of the reported strengths have an available source from the two manufacturers on this record. That includes the 3 grams/10 mL vial (x10), the 2 mL multiple dose vial, and the 600 mg/2 mL vial (x10). Because there is no strength currently showing supply, I want you to know where things stand clearly.
The reported reason is a business decision by the manufacturers to discontinue making these products. Since the status is "to be discontinued," this supply problem may be permanent for these specific items, which makes a conversation with your prescriber the right next step. Even so, this record reflects only these two manufacturers — other companies still list the same medicine.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to check wholesalers and other makers; the same medicine (Lincomycin Hydrochloride 300 mg/mL injection) is listed from Pharmacia & Upjohn, Sagent, and XGen, though it may not be in local stock.
- If your product cannot be found, ask your prescriber or pharmacist about a clinician-chosen option.
This is national, manufacturer-reported data and may not match your pharmacy's actual stock. Manufacturer phone numbers are listed on this page for reference; pharmacies usually make those calls.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Where else can I get Lincomycin Hydrochloride Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Lincomycin Hydrochloride Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Lincocin | LINCOMYCIN HYDROCHLORIDE 300 mg/mL | Injection, Solution · Intramuscular, Intravenous, Subconjunctival | Pharmacia & Upjohn Company LLC | 00009-0107-04 |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE 300 mg/mL | Injection, Solution · Intramuscular, Intravenous, Subconjunctival | Sagent Pharmaceuticals | 25021-0193-02 |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE 300 mg/mL | Injection, Solution · Intramuscular, Intravenous, Subconjunctival | XGen Pharmaceuticals DJB, Inc. | 39822-0353-06 |
Alternative dosage forms of Lincomycin Hydrochloride
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 14 productsclick to expand
Orange Book–rated equivalents of the affected strengths / sizes, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Lincocin 300 mg/mL | Pharmacia | 1 vial | — | AP | FDA listed |
| Lincocin 300 mg/mL | Pharmacia | 1 vial | — | AP | FDA listed |
| Lincomycin 3000 mg/10mL | PAI | 10 vials | — | AP | FDA listed |
| Lincomycin 300 mg/mL | Henry | 1 vial | — | AP | FDA listed |
| Lincomycin 300 mg/mL | Sagent | 10 vials | — | AP | FDA listed |
| Lincomycin 300 mg/mL | XGen | 10 vials | — | AP | FDA listed |
| Lincomycin 300 mg/mL | XGen | 10 ml | — | AP | FDA listed |
| Lincomycin 300 mg/mL | Micro | 1 vial | — | AP | FDA listed |
| lincomycin hydrochloride 300 mg/mL | Gland | 1 vial | — | AP | FDA listed |
| Lincomycin hydrochloride 300 mg/mL | Gland | 1 vial | — | AP | FDA listed |
| lincomycin 300 mg/mL | Slate | 10 vials | — | — | FDA listed |
| lincomycin 300 mg/mL | Slate | 1 vial | — | — | FDA listed |
| Lincomycin 600 mg/2mL | Armas | 1 vial | — | AP | FDA listed |
| Lincomycin 3000 mg/10mL | Armas | 10 vials | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Lincomycin Hydrochloride Injection — that fall in the same broad treatment class (lincosamide antibiotics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other anti-infective shortages
Lincomycin Hydrochloride Injection shortage FAQs
Is Lincomycin Hydrochloride Injection in shortage?
Which products are affected?
When will Lincomycin Hydrochloride Injection be available again?
Can I still get Lincomycin Hydrochloride somewhere?
What should I do if I take Lincomycin Hydrochloride Injection?
Still have a question about the Lincomycin Hydrochloride Injection shortage?
Ask a pharmacist about this shortage →View Lincomycin Hydrochloride Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.